Evidence map›Paper›PMID 30544401›Full record

ArticleMedicine2018

Case report of dysregulation of primary bile acid synthesis in a family with X-linked adrenoleukodystrophy.

Teresa Płatek, Evelyn Orso, Barbara Zapała, Anna Polus, Beata Kieć-Wilk, Monika Piwowar, Monika Chojnacka, Urszula Ciałowicz, Małgorzata Malczewska-Malec, Gerd Schmitz and 2 more

Open access · goldAbstract readCase Reports
In one paragraph

Article in Medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Bile Acid Signaling in Neurodegenerative and Neurological Disorders.International journal of molecular sciences · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Teresa PłatekDepartment of Clinical Biochemistry, Jagiellonian University Medical College, Krakow, Poland.
Evelyn OrsoInstitute for Clinical Chemistry and Laboratory Medicine, University Hospital Regensburg, Regensburg, Germany.
Barbara ZapałaDepartment of Clinical Biochemistry, Jagiellonian University Medical College, Krakow, Poland.
Anna PolusDepartment of Clinical Biochemistry, Jagiellonian University Medical College, Krakow, Poland.
Beata Kieć-WilkDepartment of Metabolic Diseases, University Hospital Krakow.
Monika PiwowarDepartment of Bioinformatics and Telemedicine, Jagiellonian University Medical College, Krakow, Poland.
Monika ChojnackaDepartment of Clinical Biochemistry, Jagiellonian University Medical College, Krakow, Poland.
Urszula CiałowiczDepartment of Clinical Biochemistry, Jagiellonian University Medical College, Krakow, Poland.
Małgorzata Malczewska-MalecDepartment of Clinical Biochemistry, Jagiellonian University Medical College, Krakow, Poland.
Gerd SchmitzInstitute for Clinical Chemistry and Laboratory Medicine, University Hospital Regensburg, Regensburg, Germany.
Bogdan SolnicaDepartment of Clinical Biochemistry, Jagiellonian University Medical College, Krakow, Poland.
Aldona Dembińska-KiećDepartment of Clinical Biochemistry, Jagiellonian University Medical College, Krakow, Poland.
Jagiellonian University · PLUniversity Hospital Regensburg · DEKrakow Cardiovascular Research Institute · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

rationaleX-linked adrenoleukodystrophy (X-ALD) is a rare disorder caused by mutations in the ABCD1 gene, coding for peroxisomal membrane transporter adrenoleukodystrophy (ALD) protein. The disease is characterized by accumulation of very long chain fatty acids (VLCFAs) in tissues. Adult adrenomyeloneuropathy (AMN) and the cerebral inflammatory form of ALD are the main phenotypes presenting various symptoms. PATIENT CONCERNS: We report a case of 37-year-old patient with diagnosis of X-ALD, confirmed based on elevated VLCFA concentrations and genetic testing of ABCD1 gene. The complete clinical picture in the patient indicates AMN phenotype with cerebral involvement. DIAGNOSES: The reduced synthesis of unconjugated cholic and chenodeoxycholic acids, and the reduction to 28% to 29% of peroxisomal beta-oxidation of behenic acid and normal peroxisomal metabolism of pristanic and palmitic acid were observed in the X-ALD patient. Sanger sequencing of major genes involved in primary bile acid (BA) synthesis failed to identify pathogenic mutations of the investigated set of genes.

interventionsPlasma concentrations of BAs, VLCFAs, and beta-oxidation of C22:0, C16:0, and pristanic acid were studied in primary skin fibroblasts of the patient. In addition, we performed sequencing of the ABCD1, ABCD3, CYP7A1, CYP7B1, CYP27A1, HSD3B7, AKR1D1, and SLC27A5 genes in the X-ALD family. OUTCOMES: In the Polish family affected with AMN a dysregulation of the primary BA synthesis pathway was found. LESSONS: We have demonstrated the coincidence of the adult form of X-ALD with abnormalities in BA synthesis. We suggest that decreased synthesis of BAs may be an additional dysfunction as a consequence of the ABCD1 c.659T>C, p.(Leu220Pro) mutation and may be further evidence that disturbed cholesterol metabolism is important in the pathology of ALD.

Indexed as

AdrenoleukodystrophyAdultATP Binding Cassette Transporter, Subfamily D, Member 1Bile Acids and SaltsCells, CulturedFamilyFibroblastsGene ExpressionHumansMaleABCD1 protein, humanATP Binding Cassette Transporter, Subfamily D, Member 1Bile Acids and Salts

Identifiers

PMID30544401
PMCPMC6310492
OpenAlexW2905061363

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.